Trial intelligence / Profile preview

Momordica Charantia Extract vs DHP for Uncomplicated Malaria

NCT06036030Phase 2Completed

Start
Jan 2019
Primary completion
Apr 2019
Modality
Botanical Extract
Countries
1
01

Overview

A Phase 2 trial of momordica charantia extract in Plasmodium falciparum malaria, malaria. Started Jan 2019; status: completed.

02

Drugs

momordica charantia extract
03

Conditions

Plasmodium falciparum malariamalaria

Beyond the preview

Go deeper on NCT06036030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06036030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call